ublituximab
Drug Details
- Generic Name
- ublituximab
- Brand Names
- BRIUMVI
- Application Number
- BLA761238
- Sponsor
- SAMSUNG BIOLOGICS Co., Ltd.
- NDC Codes
- 3
- Dosage Forms
- LIQUID, SOLUTION, INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- UBLITUXIMAB-XIIY, UBLITUXIMAB
Indications and Usage
1 INDICATIONS AND USAGE BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BRIUMVI is a CD20-directed cytolytic antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 , 14 ).